Market cap
₹4 Cr
Revenue (TTM)
₹18 Cr
P/E Ratio
69.8
P/B Ratio
1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 196.44 | 62.53 | 19.13 |
| EBIT | -- | -- | 28.84 | 21.38 | -19.25 |
| Net Profit | -- | -- | 177.10 | 41.03 | 13.87 |
| EPS | -- | -- | 177.06 | 41.03 | -- |
| Book Value | -- | -- | 3.17 | 1.48 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -- | 0.98 | 0.17 | 0.36 | 0.09 |
| Net Margin
| -- | 0.79 | 0.33 | 0.17 | 0.32 |
| Return on equity
| -- | 1.87 | 1.46 | 0.87 | 0.26 |
| Return on Capital
| -- | 2.97 | 5.62 | 1.76 | 0.56 |
| Return on Assets
| -- | 0.89 | 0.37 | 0.35 | 0.22 |
| Debt to Equity (x)
| -- | -- | 0.43 | 0.31 | 0.10 |
Profitability
ROCE
5.62
Lower than Peers by 8.61
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
5.62
|
1.76
|
0.56
|
--
|
--
|
|
Peer Median
|
14.23
|
13.72
|
22.53
|
4.15
|
--
|
ROE
1.46
Lower than Peers by 7.88
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
1.46
|
0.87
|
0.26
|
--
|
--
|
|
Peer Median
|
9.34
|
9.55
|
16.92
|
2.80
|
--
|
ROA
0.37
Lower than Peers by 5.09
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
0.37
|
0.35
|
0.22
|
--
|
--
|
|
Peer Median
|
5.46
|
5.81
|
9.16
|
1.50
|
--
|
EBIT Margin
0.17
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
0.17
|
0.36
|
0.09
|
--
|
--
|
|
Peer Median
|
--
|
12.51
|
14.18
|
3.72
|
--
|
Net Margin
0.33
Lower than Peers by 2.77
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
0.33
|
0.17
|
0.32
|
--
|
--
|
|
Peer Median
|
3.10
|
3.56
|
4.62
|
4.10
|
--
|
Cash Profit Margin
0.79
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
0.79
|
0.38
|
1.26
|
--
|
--
|
|
Peer Median
|
--
|
0.00
|
--
|
0.00
|
--
|
Revenue Growth
-14.45
--
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
-14.45
|
527.44
|
--
|
--
|
--
|
|
Peer Median
|
--
|
38.08
|
18.84
|
24.28
|
--
|
EBIT Growth
-60.68
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
-60.68
|
2,549.01
|
--
|
--
|
--
|
|
Peer Median
|
--
|
460.14
|
225.64
|
-15.80
|
--
|
Net Profit Growth
70.67
--
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
70.67
|
231.49
|
--
|
--
|
--
|
|
Peer Median
|
--
|
-3.95
|
200.69
|
13.25
|
--
|
EPS Growth
70.67
--
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
70.67
|
231.71
|
--
|
--
|
--
|
|
Peer Median
|
--
|
90.91
|
--
|
13.25
|
--
|
Book Value Growth
1.46
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
1.46
|
0.72
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.43
Higher than Peers by 0.39
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
0.43
|
0.31
|
0.10
|
--
|
--
|
|
Peer Median
|
0.04
|
0.00
|
0.03
|
0.07
|
--
|
Current Ratio
1.46
Lower than Peers by 0.64
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
1.46
|
1.51
|
10.73
|
--
|
--
|
|
Peer Median
|
2.10
|
2.00
|
2.04
|
2.16
|
--
|
Quick Ratio
1.36
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
1.36
|
1.37
|
8.07
|
--
|
--
|
|
Peer Median
|
--
|
3.80
|
3.16
|
2.23
|
--
|
Interest Coverage
2.42
Lower than Peers by 13.81
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
2.42
|
2.32
|
1.91
|
--
|
--
|
|
Peer Median
|
16.23
|
8.29
|
13.76
|
3.36
|
--
|
Operating Efficiency
Debtors to sales
78.57
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
78.57
|
59.82
|
75.21
|
--
|
--
|
|
Peer Median
|
--
|
27.50
|
40.47
|
26.09
|
--
|
Asset Turnover
1.09
--
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
1.09
|
2.07
|
0.67
|
--
|
--
|
|
Peer Median
|
--
|
1.26
|
1.17
|
0.64
|
--
|
Receivable days
271.00
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
271.00
|
131.05
|
274.52
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
25.68
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
25.68
|
21.83
|
128.97
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
235.42
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
235.42
|
93.03
|
46.16
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
61.26
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
61.26
|
59.85
|
357.33
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
84.19
Higher than Peers by 53.35
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
84.19
|
--
|
583.66
|
--
|
--
|
|
Peer Median
|
30.84
|
47.94
|
40.22
|
94.75
|
--
|
Price / Book Value
1.22
Lower than Peers by 5.15
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
1.22
|
--
|
1.53
|
--
|
--
|
|
Peer Median
|
6.38
|
4.56
|
4.89
|
3.81
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
0.08
|
--
|
--
|
--
|
EV/EBITDA
16.66
Lower than Peers by 13.38
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
16.66
|
25.23
|
113.35
|
--
|
--
|
|
Peer Median
|
30.04
|
35.83
|
23.03
|
-2.86
|
--
|
Market Cap
5
Lower than Peers by 263
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Fabino Life Sci
|
5
|
--
|
6
|
--
|
--
|
|
Peer Median
|
268
|
133
|
112
|
40
|
--
|